Utility of enzyme immunoassays for diagnosis of subacute sclerosing panencephalitis
- PMID: 32239783
- DOI: 10.1111/ped.14244
Utility of enzyme immunoassays for diagnosis of subacute sclerosing panencephalitis
Abstract
Background: Subacute sclerosing panencephalitis (SSPE) is a progressive neurologic disorder caused by the measles virus (MV) and is identified by positive MV-specific antibody titers, detected mainly by hemagglutination inhibition (HI) tests in the cerebrospinal fluid (CSF). However, an alternative method, the enzyme immunoassay (EIA), has increasingly become a preferred method for detecting MV antibodies. To establish the index for SSPE diagnosis using EIA, we investigated the correlation between HI and EIA titers of MV antibodies in SSPE patients.
Methods: Data on MV antibody titers and measurement methods at the time of diagnosis in 89 Japanese SSPE cases diagnosed between 1979 and 2006 were obtained by a survey. We also assessed the serum and CSF MV antibody titers in three patients with SSPE and serum MV antibody titers in 38 healthy adults using immunoglobulin G (IgG)-EIA and HI.
Results: In all cases diagnosed as SSPE, IgG-EIA titers in the CSF were ≥0.49 IU/mL. There was a positive correlation between serum antibody values in the controls measured by IgG-EIA and HI. In patients with SSPE, both serum and CSF antibody values, measured by IgG-EIA, and HI, were positively correlated, and a positive correlation was found between the serum and CSF MV antibody titers as measured by IgG-EIA. The serum/CSF MV antibody titer ratios determined by IgG-EIA were <20 in most SSPE patients.
Conclusions: Immunoglobulin G-EIA may be a suitable alternative method for SSPE diagnosis; however, its potential utility and the cut-off point of ≥0.49 IU/mL should be tested with additional patient cohorts.
Keywords: diagnosis; enzyme immunoassay; measles; specific antibody; subacute sclerosing panencephalitis.
© 2020 Japan Pediatric Society.
References
-
- Rota PA, Rota JS, Goodson JL. Subacute sclerosing panencephalitis. Clin. Infect. Dis. 2017; 65: 233-4.
-
- Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int. J. Epidemiol. 2007; 36: 1334-8.
-
- Wendorf KA, Winter K, Zipprich J et al. Subacute sclerosing panencephalitis: The devastating measles complication that might be more common than previously estimated. Clin. Infect. Dis. 2017; 65: 226-32.
-
- Jafri SK, Kumar R, Ibrahim SH. Subacute sclerosing panencephalitis - current perspectives. Pediatr. Health Med. Ther. 2018; 9: 67-71.
-
- Abe Y, Hashimoto K, Iinuma K et al. Survey of subacute sclerosing panencephalitis in Japan. J. Child Neurol. 2012; 27: 1529-33.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources